NovoCure Limited - Ordinary Shares (NVCR)
29.66
0.00 (0.00%)
Novocure Ltd is a biotechnology company that focuses on developing and commercializing innovative treatments for cancer
The company's primary technology is Tumor Treating Fields (TTFields), a non-invasive therapy that utilizes electric fields to disrupt cancer cell division and inhibit tumor growth. Novocure partners with healthcare providers to bring its advanced therapies to patients suffering from various types of tumors, particularly aggressive forms of cancer. Through ongoing research and collaboration, Novocure aims to improve treatment options and outcomes for patients battling cancer, employing a unique approach that integrates with existing treatment modalities.
Frequently Asked Questions
Is NovoCure Limited - Ordinary Shares publicly traded?
Yes, NovoCure Limited - Ordinary Shares is publicly traded.
What exchange does NovoCure Limited - Ordinary Shares trade on?
NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NovoCure Limited - Ordinary Shares?
The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market
What is the current price of NovoCure Limited - Ordinary Shares?
The current price of NovoCure Limited - Ordinary Shares is 29.66
When was NovoCure Limited - Ordinary Shares last traded?
The last trade of NovoCure Limited - Ordinary Shares was at 4:00 pm EST on January 6th, 2025
What is the market capitalization of NovoCure Limited - Ordinary Shares?
The market capitalization of NovoCure Limited - Ordinary Shares is 3.07B
How many shares of NovoCure Limited - Ordinary Shares are outstanding?
NovoCure Limited - Ordinary Shares has 103.65M shares outstanding.